Treatment of central serous chorioretinopathy with topical NSAIDs.

Bahadorani, Sepehr; Maclean, Kyle; Wannamaker, Kendall; Chu, Edward Rickie; Gresores, Nathan; Sohn, Jeong-Hyeon; Diaz-Rohena, Roberto; Singer, Michael A

Bahadorani, Sepehr; Maclean, Kyle; Wannamaker, Kendall; Chu, Edward Rickie; Gresores, Nathan; Sohn, Jeong-Hyeon; Diaz-Rohena, Roberto; Singer, Michael A.

Afiliación

Bahadorani S; Department of Ophthalmology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Maclean K; Department of Ophthalmology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Wannamaker K; Department of Ophthalmology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Chu ER; Department of Ophthalmology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Gresores N; Medical Center Ophthalmology Associates, San Antonio, TX, USA.
Sohn JH; Department of Ophthalmology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Diaz-Rohena R; Department of Ophthalmology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Singer MA; Medical Center Ophthalmology Associates, San Antonio, TX, USA.

Clin Ophthalmol ; 13: 1543-1548, 2019.

Article en En | MEDLINE | ID: mdl-31616132

Palabras clave

CSC; CSCR; NSAIDs; SRF; bromfenac; central serous chorioretinopathy; nepafenac; subretinal fluid

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Clin Ophthalmol Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google